673 results on '"Gardner, Ginger"'
Search Results
152. Cost-effectiveness of routine vaginal cytology for endometrial cancer surveillance
153. Salvage cytoreductive surgery for recurrent endometrial cancer
154. Incidence of Venous Thromboembolism After Minimally Invasive Surgery in Patients With Newly Diagnosed Endometrial Cancer
155. VAGINAL CUFF DEHISCENCE AFTER ROBOTICALLY ASSISTED PROCEDURES REQUIRING A COLPOTOMY: (P079)
156. INTEGRATION AND TRAINING OF ROBOTICALLYASSISTED SURGERY IN A GYNECOLOGIC ONCOLOGY FELLOWSHIP PROGRAM: (P080)
157. POSTOPERATIVE PAIN MEDICATION REQUIREMENTS IN PATIENTS UNDERGOING ROBOTICALLY ASSISTED AND STANDARD LAPAROSCOPIC PROCEDURES FOR NEWLY DIAGNOSED ENDOMETRIAL CANCER: (P078)
158. COMPARISON OF ROBOTICALLY ASSISTED AND STANDARD LAPAROSCOPIC PROCEDURES IN PATIENTS WITH ENDOMETRIAL CANCER: (S053)
159. SENTINEL LYMPH NODE MAPPING IN PATIENTS WITH ENDOMETRIAL CANCER UNDERGOING ROBOTICALLY ASSISTED OR STANDARD LAPAROSCOPIC PROCEDURES: (S036)
160. Pre-operative neoadjuvant chemotherapy cycles and survival in newly diagnosed ovarian cancer: what is the optimal number? A Memorial Sloan Kettering Cancer Center Team Ovary study
161. Comparison of minimally invasive versus open surgery in the treatment of endometrial carcinosarcoma
162. Delays from neoadjuvant chemotherapy to interval debulking surgery and survival in ovarian cancer
163. Surveillance patterns of cervical cancer patients treated with conization alone
164. Risk of venous thromboembolism in patients receiving neoadjuvant chemotherapy for ovarian cancer.
165. A randomized phase II trial of secondary cytoreductive surgery (SCS) +/- carboplatin hyperthermic intraperitoneal chemotherapy (HIPEC) in patients (pts) with recurrent platinum-sensitive ovarian cancer (EOC).
166. A single-arm, prospective trial investigating the effectiveness of a non-hormonal vaginal moisturizer containing hyaluronic acid in postmenopausal cancer survivors
167. Characteristics and survival of ovarian cancer patients treated with neoadjuvant chemotherapy but not undergoing interval debulking surgery
168. Surgical care of elderly women with ovarian cancer: A population-based perspective
169. Laparoscopic lymphadenectomy for gynecologic malignancies using ultrasonically activated shears: Analysis of first 100 cases
170. Centralization of Care for Patients With Advanced-Stage Ovarian Cancer: A cost-effectiveness analysis
171. Secondary Cytoreductive Surgery for Localized, Recurrent Epithelial Ovarian Cancer: Analysis of prognostic factors and survival outcome
172. Risk of Epithelial Ovarian Cancer Recurrence in Patients With Rising Serum CA-125 Levels Within the Normal Range
173. Phase II trial of the combination of bryostatin-1 and cisplatin in advanced or recurrent carcinoma of the cervix: a New York Gynecologic Oncology Group study
174. Ovarian Tumors of Low Malignant Potential: Can Molecular Biology Solve This Enigma?
175. Understanding Inherited Risk in Unselected Newly Diagnosed Patients With Endometrial Cancer
176. Radiogenomics Analysis of Intratumor Heterogeneity in a Patient With High-Grade Serous Ovarian Cancer
177. The development and implementation of a gynecologic cancer survivorship tool.
178. State of the science: Evolving role of surgery for the treatment of ovarian cancer
179. THE IMPACT OF PATIENT TRAVEL DISTANCE ON QUALITY INDICATORS IN GYNECOLOGIC SURGERY
180. OVARIAN CANCER CARE DELIVERY: DIVERSITY IN PUBLIC PERCEPTION AND ACCESS TO CARE
181. U.S. SURVEY ON PROVIDER SURVEILLANCE PATTERNS IN PATIENTS WITH STAGE I CERVICAL CANCER AFTER CERVICAL CONIZATION
182. Delays from neoadjuvant chemotherapy to interval debulking surgery and survival in ovarian cancer.
183. Factors associated with one-year mortality after debulking surgery in older women with ovarian cancer.
184. Clinical Outcomes for Salvage High-Dose-Rate Brachytherapy in Patients with Recurrent Endometrial Cancer
185. Ovarian Cancer Care Delivery : Diversity in Public Perception and Access To Care
186. Delays from neoadjuvant chemotherapy to interval debulking surgery and survival in ovarian cancer.
187. Is Robotic-Assisted Surgery Safe in the Elderly Population? An Analysis of Gynecologic Procedures in Patients ≥ 65 Years Old
188. 2149
189. Multi gene panel testing in unselected patients (pts) with endometrial cancer (EC).
190. A Comparison of the Detection of Sentinel Lymph Nodes Using Indocyanine Green and Near-Infrared Fluorescence Imaging Versus Blue Dye During Robotic Surgery in Uterine Cancer
191. Is Robotic-Assisted Surgery Safe in the Elderly Population? An Analysis of Gynecologic Procedures in Patients ≥ 65 Years Old.
192. Abdominal wall endometriosis: differentiation from other masses using CT features
193. Intraperitoneal chemotherapy after interval debulking surgery for advanced-stage ovarian cancer: Feasibility and outcomes at a comprehensive cancer center
194. Robotically Assisted Laparoscopic Ovarian Transposition in Women with Lower Gastrointestinal Cancer Undergoing Pelvic Radiotherapy
195. Corrigendum to “Cited rationale for variance in the use of primary intraperitoneal chemotherapy following optimal cytoreduction for stage III ovarian carcinoma at a high intraperitoneal chemotherapy utilization center” [Gynecol. Oncol. 142 (2016) 13–18]
196. Diverting ileostomy during primary debulking surgery for ovarian cancer: Associated factors and postoperative outcomes
197. Cited rationale for variance in the use of primary intraperitoneal chemotherapy following optimal cytoreduction for stage III ovarian carcinoma at a high intraperitoneal chemotherapy utilization center
198. A pilot study of topical imiquimod therapy for the treatment of recurrent extramammary Paget's disease
199. Stage IA2 cervical cancer: Long-term outcomes with less radical as opposed to more radical surgical management.
200. Fertility-sparing surgery in stage IA2 cervical cancer: Associated factors and long-term survival.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.